HENRY SCHEIN, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
HENRY SCHEIN, INC. (HSIC) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $566.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-02-21
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-12-25 was $151.62M, a 3.40% increase year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-09-25 was $169.47M, a 11.63% increase year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-06-26 was $163.98M.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-03-27 was $174.93M, a 30.69% increase year-over-year.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $566.00M, a 14.24% decline from fiscal 2021.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was $660.00M, a 57.52% increase from fiscal 2020.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was $419.00M, a 42.24% decline from fiscal 2019.
- HENRY SCHEIN, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was $725.46M, a 61.06% increase from fiscal 2018.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $566.00M 10-K · filed 2023-02-21 | ||||
| 2021-12-25 | $151.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $321.10M derived: sum of 2 quarters · filed 2023-02-21 | $485.07M derived: sum of 3 quarters · filed 2023-02-21 | $660.00M 10-K · filed 2023-02-21 | $660.53M 10-K · filed 2022-02-15 |
| 2021-09-25 | $169.47M 10-Q · filed 2021-11-02 | $333.45M derived: sum of 2 quarters · filed 2021-11-02 | $508.38M 10-Q · filed 2021-11-02 | $655.01M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2021-06-26 | $163.98M 10-Q · filed 2021-08-03 | $338.90M 10-Q · filed 2021-08-03 | $485.53M derived: sum of 3 quarters · filed 2021-08-03 | $637.35M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2021-03-27 | $174.93M 10-Q · filed 2021-05-04 | $321.56M derived: sum of 2 quarters · filed 2021-05-04 | $473.37M derived: sum of 3 quarters · filed 2021-11-02 | $459.52M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-12-26 | $146.63M 10-K · filed 2021-02-17 | $298.44M derived: sum of 2 quarters · filed 2021-11-02 | $284.59M derived: sum of 3 quarters · filed 2021-11-02 | $419.00M 10-K · filed 2023-02-21 | $418.44M 10-K · filed 2021-02-17 |
| 2020-09-26 | $151.81M 10-Q · filed 2021-11-02 | $137.96M derived: sum of 2 quarters · filed 2021-11-02 | $271.81M 10-Q · filed 2021-11-02 | $609.00M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-06-27 | -$13.85M 10-Q · filed 2021-08-03 | $120.00M 10-Q · filed 2021-08-03 | $457.19M derived: sum of 3 quarters · filed 2021-08-03 | $600.40M derived: sum of 4 quarters · filed 2021-08-03 | |
| 2020-03-28 | $133.85M 10-Q · filed 2021-05-04 | $471.04M derived: sum of 2 quarters · filed 2021-05-04 | $614.25M derived: sum of 3 quarters · filed 2021-05-04 | $735.67M derived: sum of 4 quarters · filed 2021-05-04 | |
| 2019-12-28 | $337.19M 10-K · filed 2021-02-17 | $480.40M derived: sum of 2 quarters · filed 2021-02-17 | $601.82M derived: sum of 3 quarters · filed 2021-02-17 | $725.46M 10-K · filed 2022-02-15 | |
| 2019-09-28 | $143.21M 10-K · filed 2021-02-17 | $264.63M derived: sum of 2 quarters · filed 2021-02-17 | $388.27M 10-Q · filed 2020-11-02 | $513.15M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-29 | $121.42M 10-K · filed 2021-02-17 | $245.06M 10-Q · filed 2020-08-04 | $369.94M derived: sum of 3 quarters · filed 2021-02-17 | $466.19M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-30 | $123.64M 10-K · filed 2021-02-17 | $248.53M derived: sum of 2 quarters · filed 2021-02-17 | $344.77M derived: sum of 3 quarters · filed 2021-02-17 | $459.36M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-29 | $124.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $221.13M derived: sum of 2 quarters · filed 2021-02-17 | $335.72M derived: sum of 3 quarters · filed 2021-02-17 | $450.44M 10-K · filed 2021-02-17 | |
| 2018-09-29 | $96.25M 10-Q · filed 2019-11-05 | $210.84M derived: sum of 2 quarters · filed 2019-11-05 | $325.56M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $114.59M 10-Q · filed 2019-08-06 | $229.31M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $114.72M 10-Q · filed 2019-05-07 | ||||
| 2017-12-30 | $318.48M 10-K · filed 2020-02-20 | ||||
| 2011-12-31 | $404.66M 10-K · filed 2012-02-15 | ||||
| 2010-12-25 | $97.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-15 | $191.72M derived: sum of 2 quarters · filed 2012-02-15 | $284.88M derived: sum of 3 quarters · filed 2012-02-15 | $352.13M 10-K · filed 2012-02-15 | |
| 2010-09-25 | $94.49M 10-Q · filed 2010-10-29 | $187.65M derived: sum of 2 quarters · filed 2010-10-29 | $254.91M 10-Q · filed 2010-10-29 | ||
| 2010-06-26 | $93.16M 10-Q · filed 2010-08-02 | $160.41M 10-Q · filed 2010-08-02 | |||
| 2009-12-26 | $92.68M 10-K · filed 2011-02-22 | $191.06M derived: sum of 2 quarters · filed 2011-02-22 | $271.26M derived: sum of 3 quarters · filed 2011-02-22 | $330.44M 10-K · filed 2012-02-15 | |
| 2009-09-26 | $98.38M 10-K · filed 2011-02-22 | $178.57M derived: sum of 2 quarters · filed 2011-02-22 | $237.76M 10-Q · filed 2010-10-29 | ||
| 2009-06-27 | $80.20M 10-K · filed 2011-02-22 | $139.38M 10-Q · filed 2010-08-02 | |||
| 2009-03-28 | $59.18M 10-K · filed 2011-02-22 | ||||
| 2008-12-27 | $269.28M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |